| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 45,073 | 44,562 | 45,239 | 46,167 | | Cost of Revenue | 4,759 | 4,677 | 5,467 | 5,272 | | | Gross Profit | 40,314 | 39,885 | 39,772 | 40,895 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,222 | 3,307 | 3,023 | 3,053 | | Non Recurring |
-
|
-
|
-
| (354) | | Others | 4,769 | 21,146 | 13,318 | 13,464 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 32,323 | 15,432 | 23,431 | 24,732 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 10,269 | 13,842 | (4,429) | (19,102) | | Earnings Before Interest And Taxes | 32,763 | 29,259 | 19,017 | 5,630 | | Interest Expense | 22,386 | 22,673 | 23,061 | 24,467 | | Income Before Tax | 10,377 | 6,586 | (4,044) | (18,837) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
| (15) | 15 | 95 | | | | Net Income From Continuing Ops | (3,386) | 6,586 | (4,044) | (18,742) | | | Non-recurring Events | | Discontinued Operations |
-
| 83 | 113 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,377) | 6,669 | (3,931) | (18,742) | | Preferred Stock And Other Adjustments | (707) | (715) | (711) | (711) | | | Net Income Applicable To Common Shares | ($4,084) | $5,954 | ($4,642) | ($19,453) |
|
0.20% Nasdaq 
0.44 (9.15%) 
Income Statement
